Senior Editor · Editorial staff
Isadora Velazquez
Leads the publication's coverage of medically supervised weight solutions and edits every story for accuracy and plain English.
12 stories by Isadora Velazquez
The ScienceRetatrutide: what the triple-agonist trials show and how it differs from semaglutide and tirzepatide
Retatrutide hits three hormone receptors instead of one or two, and its mid-stage trial produced the largest average weight loss reported for an obesity drug so far. Here is what the data actually shows, why the third pathway matters, and where the medication stands with the FDA.
· Isadora Velazquez
The ScienceGLP-1s and sleep apnea: the first drug approved for the condition
The first medication ever cleared to treat obstructive sleep apnea is a GLP-1 class drug. Here is what the SURMOUNT-OSA trial showed, who the approval covers, and why it complements rather than replaces a CPAP machine.
· Isadora Velazquez
The ScienceGLP-1s and your heart: what the cardiovascular evidence shows
The biggest news about these medications may not be the weight. Here is what the landmark SELECT trial found, who the heart benefit actually applies to, and what it changes about the decision to start or stay on treatment.
· Isadora Velazquez
The ScienceGLP-1s, prediabetes, and metabolic risk
These drugs were born in diabetes care, and the metabolic story is bigger than the scale.
· Isadora Velazquez
The ScienceGLP-1s and alcohol: what the early research suggests
Patients keep reporting they want to drink less, and researchers are starting to take the signal seriously.
· Isadora Velazquez
The ScienceFood noise: what GLP-1 patients mean by a quieter mind
Patients keep describing the same thing: the constant background chatter about food simply goes quiet.
· Isadora Velazquez
The ScienceBeyond the scale: the metabolic markers worth tracking
Weight is the slowest, least informative number you track. These lab values predict your health far better.
· Isadora Velazquez
The ScienceHitting a plateau on a GLP-1: what is normal and what to do
Plateaus are a normal part of weight loss, not a sign the medication has stopped working or that you have failed.
· Isadora Velazquez
The ProceduresWhen weight-loss surgery makes sense
Bariatric surgery is a serious tool for serious situations.
· Isadora Velazquez
The ScienceStubborn fat vs. weight loss: two different problems
Why diet and exercise leave certain areas untouched, and what does.
· Isadora Velazquez
The ScienceWhy skin sags after weight loss, and what helps
The elasticity question, and the realistic options for loose skin.
· Isadora Velazquez
The ProceduresAfter major weight loss: where body contouring fits
Losing the weight is one chapter; addressing loose skin is another.
· Isadora Velazquez